Dr. Aguirre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2023 - 2024
Harvard School of Public HealthPCE, 2023 - 2024
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2020 - 2023
University of Miami Hospital and Clinics/Holy Cross HospitalResidency, Internal Medicine, 2017 - 2020
Universidad Catolica de Santiago de GuayaquilClass of 2013
Certifications & Licensure
FL State Medical License 2017 - Present
MA State Medical License 2023 - Present- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 51 citationsImmune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging IssueLuis E. Aguirre, Maria E. Guzman, Gilberto Lopes, Judith Hurley
The Oncologist. 2019-03-01 - 1 citationsData-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti
The Lancet. Haematology. 2024-11-01 - 20 citationsAssessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes.Luis E Aguirre, Najla Al Ali, David A Sallman, Somedeb Ball, Akriti G Jain
Leukemia. 2023-07-01
Abstracts/Posters
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceLuis E. Aguirre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceLuis E. Aguirre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Portuguese, French, German, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
